Stock Details
SNY is Sanofi's stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 41.54$. Average daily volumn in 3 months 2.83M. Market cap 116.28B



Stock symbol : SNY. Exchange : NasdaqGS. Currency : USD
Lastest price : 45.87$. Total volume : 1.99M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Sanofi (SNY)
Last Price
45.87$
Change
0.52
Volume
1.99M

Previous Close45.35
Open45.90
Day Range45.62-46.02
Bid0.00 x 1k
Ask0.00 x 900
Volume1.99M
Average Volume2.83M
Market Cap116.28B
Beta0.46
52 Week Range36.91-58.10
Trailing P/E17.37
Foward P/E10.26
Dividend (Yield %)3.81%
Ex-Dividend Date2022-05-26



Financial Details


According to Sanofi's financial reports the company's revenue in 2021 were 39.17B an increase( +5.41%) over the years 2020 revenue that were of 37.37B. In 2021 the company's total earnings were 6.22B while total earnings in 2020 were 12.29B(-50%).


Loading ...



Organization

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines ... for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Market Cap:
116.28B
Revenue:
39.17B
Total Assets:
120.24B
Total Cash:
10.1B



News about "Sanofi"

sanofi-employees-renew-strike-after-failed-pay-rise-talks-image

Sanofi employees renew strike after failed pay rise talks

Source from : EURACTIV - 11 hours ago

Sanofi’s employees decided to renew the industrial action on Thursday after negotiations with management for higher wages in the context of inflation failed. The strike, called by the four main French ...See details»


Press Release: Statement from Sanofi regarding: rule 2.12 of the takeover rules

Source from : YAHOO!Finance - 11 hours ago

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE "TAKEOVER RULES"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, ...See details»


sanofi-dndis-drug-shows-success-rates-of-up-to-95-for-sleeping-sickness-in-trial-image

Sanofi, DNDi's drug shows success rates of up to 95% for sleeping sickness in trial

Source from : Seeking Alpha - 2 days ago

Sanofi (SNY) said a single-dose of acoziborole showed treatment success rates of up to 95% in a phase 2/3 trial in patients with sleeping sickness.Sanofi noted that the results ...See details»


uk-regulator-says-reactions-in-eye-from-sanofi-drug-must-be-quickly-reviewed-image

UK regulator says reactions in eye from Sanofi drug must be quickly reviewed

Source from : Reuters - 2 days ago

Sanofi logo at the company's headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/File Photo Nov 29 (Reuters) - Britain's medicines ...See details»


uk-regulator-calls-for-review-of-reactions-in-eyes-to-sanofi-asthma-drug-image

UK regulator calls for review of reactions in eyes to Sanofi asthma drug

Source from : Reuters on MSN - 3 days ago

Sanofi logo at the company's headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/File Photo ...See details»


sanofi-welcomes-500-staffers-to-new-paris-hq-after-30m-renovation-image

Sanofi wel­comes 500 staffers to new Paris HQ af­ter €30M ren­o­va­tion

Source from : ENDPOINTS NEWS - 3 days ago

When Paul Hudson took the helm at Sanofi back in 2019, he promised to reinvent the pharma giant — including its Paris headquarters. This week, the company set up shop in new “state-of-the-art” digs.See details»


Media Update: Sanofi to present new clinical data reinforcing novel therapies across rare blood disorders at ASH 2022

Source from : sanofi - 2 days ago

Sanofi to present new clinical data reinforcing novel therapies across rare blood disorders at ASH 2022. Quality of life data for efanesoctocog alfa supports its potential as a tr ...See details»


Sanofi (SNYNF) Receives a Hold from Barclays

Source from : Business Insider - 2 days ago

In a report released today, Emily Field from Barclays maintained a Hold rating on Sanofi (SNYNF - Research Report), with a price target of ...See details»


Sanofi Drug Raises Hopes of Wiping Out Sleeping Sickness

Source from : Bloomberg L.P. - 2 days ago

A drug co-developed by Sanofi is highly effective at treating the sometimes lethal disease called sleeping sickness and could help eradicate the ailment by the end of the decade. While the disease is ...See details»


Sanofi signs latest billion-dollar AI drug discovery deal

Source from : VentureBeat - 24 days ago

The research collaboration comes on the heels of several other high-value AI drug discovery partnership announcements from Sanofi, including with Atomwise in August; a partnership expansion with ...See details»


Sanofi signs research tie-up with Hong Kong’s Insilico Medicine to accelerate AI-powered drug discovery

Source from : scmp.com - 5 days ago

Sanofi has signed a strategic research collaboration with Hong Kong-based biotech firm Insilico Medicine in a deal worth up to US$1.2 billion, leveraging artificial intelligence (AI) to speed up ...See details»


Sanofi, GSK Score Late Win With EU COVID Booster Approval

Source from : U.S. News & World Report - 22 days ago

Sanofi, GSK Score Late Win With EU COVID Booster Approval By Ludwig Burger (Reuters) -Sanofi said on Thursday it won European Union approval for its COVID-19 vaccine booster, jointly made with ...See details»


Sanofi Inks Another AI Alliance, This Time Partnering With Insilico Medicine

Source from : MedCity News - 19 days ago

Sanofi has been an active dealmaker in the artificial intelligence space, an effort intended to beef up its capabilities in drug discovery and development. Insilico Medicine is now the latest AI ...See details»


Sanofi: Information concerning the total number of voting rights and shares – October 2022

Source from : Yahoo - 17 days ago

Sanofi a French société anonyme with a registered share capital of 2,534,952,234 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris Commercial ...See details»